Astrocytoma, Grade II Terminated Phase 2 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0063156 (Astrocytoma, Grade II)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03906448FORWARD Optune and Adjuvant TMZ in Grade II/III AstrocytomaTreatment